Sabine Rottmann

975 total citations
12 papers, 750 citations indexed

About

Sabine Rottmann is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sabine Rottmann has authored 12 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Genetics. Recurrent topics in Sabine Rottmann's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (3 papers). Sabine Rottmann is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (3 papers). Sabine Rottmann collaborates with scholars based in Germany, United States and Switzerland. Sabine Rottmann's co-authors include Bernhard Lüscher, Richard Lilischkis, Juliane Lüscher‐Firzlaff, Quinn L. Deveraux, Karen Dohmann, Matthias Austen, Jörg Vervoorts, Marc Nasoff, Kim Quon and Yan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Sabine Rottmann

12 papers receiving 745 citations

Peers

Sabine Rottmann
Soula Ganiatsas United States
Jingyin Yue United States
Peng Yue United States
Katherine Ewings United Kingdom
Antony Letai United States
Margret B. Einarson United States
Arthur T. Hoang United States
Soula Ganiatsas United States
Sabine Rottmann
Citations per year, relative to Sabine Rottmann Sabine Rottmann (= 1×) peers Soula Ganiatsas

Countries citing papers authored by Sabine Rottmann

Since Specialization
Citations

This map shows the geographic impact of Sabine Rottmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Rottmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Rottmann more than expected).

Fields of papers citing papers by Sabine Rottmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Rottmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Rottmann. The network helps show where Sabine Rottmann may publish in the future.

Co-authorship network of co-authors of Sabine Rottmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Rottmann. A scholar is included among the top collaborators of Sabine Rottmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Rottmann. Sabine Rottmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shahmoradgoli, Maria, Andrew M. Hau, Oscar Betancourt, et al.. (2025). Abstract 1159: Preclinical characterization of a novel STEAP1 antibody-drug conjugate ADRX-0405 for the treatment of mCRPC. Cancer Research. 85(8_Supplement_1). 1159–1159. 1 indexed citations
2.
Shahmoradgoli, Maria, Andrew M. Hau, Anna Wang, et al.. (2024). Abstract 1902: ADRX-0706 Nectin-4 antibody-drug conjugate PK/PD characterization elucidates its widened therapeutic window. Cancer Research. 84(6_Supplement). 1902–1902. 2 indexed citations
3.
Hau, Andrew M., Maria Shahmoradgoli, Dong Jun Lee, et al.. (2024). Abstract 1891: Preclinical characterization of ADRX-0706: A next-generation anti-Nectin-4 antibody-drug conjugate with improved therapeutic window. Cancer Research. 84(6_Supplement). 1891–1891. 2 indexed citations
4.
Dierks, Christine, Francisco Adrián, Paul Fisch, et al.. (2010). The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease. Cancer Research. 70(15). 6193–6204. 51 indexed citations
5.
Kwiatkowski, Nicholas, Nannette Jelluma, P. Filippakopoulos, et al.. (2010). Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nature Chemical Biology. 6(5). 359–368. 177 indexed citations
6.
Rottmann, Sabine, et al.. (2007). Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene. The FASEB Journal. 22(4). 1124–1134. 7 indexed citations
7.
Rottmann, Sabine & Bernhard Lüscher. (2006). The Mad Side of the Max Network: Antagonizing the Function of Myc and More. Current topics in microbiology and immunology. 302. 63–122. 67 indexed citations
8.
Graaf, Katrin de, Sabine Rottmann, Len C. Packman, et al.. (2006). The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochemistry. 7(1). 7–7. 76 indexed citations
9.
Rottmann, Sabine, Caroline Bouchard, Peter Loidl, et al.. (2005). Mad1 Function in Cell Proliferation and Transcriptional Repression Is Antagonized by Cyclin E/CDK2. Journal of Biological Chemistry. 280(16). 15489–15492. 15 indexed citations
10.
Rottmann, Sabine, Yan Wang, Marc Nasoff, Quinn L. Deveraux, & Kim Quon. (2005). A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function. Proceedings of the National Academy of Sciences. 102(42). 15195–15200. 86 indexed citations
11.
Vervoorts, Jörg, Juliane Lüscher‐Firzlaff, Sabine Rottmann, et al.. (2003). Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Reports. 4(5). 484–490. 220 indexed citations
12.
Rottmann, Sabine, et al.. (2000). Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1. Journal of Biological Chemistry. 275(14). 10413–10420. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026